BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 20129763)

  • 1. Efficacy of voriconazole in a murine model of invasive paecilomycosis.
    Rodríguez MM; Pastor FJ; Serena C; Guarro J
    Int J Antimicrob Agents; 2010 Apr; 35(4):362-5. PubMed ID: 20129763
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Posaconazole efficacy in a murine disseminated infection caused by Paecilomyces lilacinus.
    Rodríguez MM; Pastor FJ; Serena C; Guarro J
    J Antimicrob Chemother; 2009 Feb; 63(2):361-4. PubMed ID: 19054804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined therapy in treatment of murine infection by Fusarium solani.
    Ruíz-Cendoya M; Mariné M; Guarro J
    J Antimicrob Chemother; 2008 Sep; 62(3):543-6. PubMed ID: 18495651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative study on the efficacy of liposomal amphotericin B and voriconazole in a murine pulmonary aspergillosis model.
    Takemoto K; Yamamoto Y; Ueda Y; Kanazawa K; Yoshida K; Niki Y
    Chemotherapy; 2009; 55(2):105-13. PubMed ID: 19151551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of antifungal therapy in a neutropenic murine model of Neoscytalidium dimidiatum infection.
    Ruíz-Cendoya M; Madrid H; Pastor J; Guarro J
    Int J Antimicrob Agents; 2010 Feb; 35(2):152-5. PubMed ID: 20005680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of voriconazole in a guinea pig model of invasive trichosporonosis.
    Serena C; Gilgado F; Mariné M; Pastor FJ; Guarro J
    Antimicrob Agents Chemother; 2006 Jun; 50(6):2240-3. PubMed ID: 16723595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of antifungal treatment in a murine model of blastoschizomycosis.
    Serena C; Mariné M; Marimon R; Pastor FJ; Guarro J
    Int J Antimicrob Agents; 2007 Jan; 29(1):79-83. PubMed ID: 17134881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of murine Fusarium verticillioides infection with liposomal amphotericin B plus terbinafine.
    Ruíz-Cendoya M; Pastor FJ; Capilla J; Guarro J
    Int J Antimicrob Agents; 2011 Jan; 37(1):58-61. PubMed ID: 20947310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined therapy against murine-disseminated infection by Fusarium verticillioides.
    Ruíz-Cendoya M; Pastor J; Guarro J
    Mycopathologia; 2011 Mar; 171(3):171-5. PubMed ID: 20853029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of voriconazole in treatment of systemic scedosporiosis in neutropenic mice.
    Capilla J; Serena C; Pastor FJ; Ortoneda M; Guarro J
    Antimicrob Agents Chemother; 2003 Dec; 47(12):3976-8. PubMed ID: 14638514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of voriconazole in a murine model of cryptococcal central nervous system infection.
    Serena C; Pastor FJ; Mariné M; Rodríguez MM; Guarro J
    J Antimicrob Chemother; 2007 Jul; 60(1):162-5. PubMed ID: 17483143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Institutional experience with voriconazole compared with liposomal amphotericin B as empiric therapy for febrile neutropenia.
    Shehab N; DePestel DD; Mackler ER; Collins CD; Welch K; Erba HP
    Pharmacotherapy; 2007 Jul; 27(7):970-9. PubMed ID: 17594202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Voriconazole -- better chances for patients with invasive mycoses.
    Ghannoum MA; Kuhn DM
    Eur J Med Res; 2002 May; 7(5):242-56. PubMed ID: 12069915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activity of aminocandin (IP960; HMR3270) compared with amphotericin B, itraconazole, caspofungin and micafungin in neutropenic murine models of disseminated infection caused by itraconazole-susceptible and -resistant strains of Aspergillus fumigatus.
    Warn PA; Sharp A; Morrissey G; Denning DW
    Int J Antimicrob Agents; 2010 Feb; 35(2):146-51. PubMed ID: 20015618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Voriconazole treatment of disseminated paecilomyces infection in a patient with acquired immunodeficiency syndrome.
    Martin CA; Roberts S; Greenberg RN
    Clin Infect Dis; 2002 Oct; 35(7):e78-81. PubMed ID: 12228840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treating disseminated fusariosis: amphotericin B, voriconazole or both?
    Ho DY; Lee JD; Rosso F; Montoya JG
    Mycoses; 2007 May; 50(3):227-31. PubMed ID: 17472622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modest efficacy of voriconazole against murine infections by Sporothrix schenckii and lack of efficacy against Sporothrix brasiliensis.
    Fernández-Silva F; Capilla J; Mayayo E; Guarro J
    Mycoses; 2014 Feb; 57(2):121-4. PubMed ID: 23879298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of caspofungin alone and in combination with voriconazole in a Guinea pig model of invasive aspergillosis.
    Kirkpatrick WR; Perea S; Coco BJ; Patterson TF
    Antimicrob Agents Chemother; 2002 Aug; 46(8):2564-8. PubMed ID: 12121933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful treatment of primary cutaneous Aspergillus ustus infection with surgical debridement and a combination of voriconazole and terbinafine.
    Krishnan-Natesan S; Chandrasekar PH; Manavathu EK; Revankar SG
    Diagn Microbiol Infect Dis; 2008 Dec; 62(4):443-6. PubMed ID: 18842377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successsful voriconazole treatment of disseminated fusarium infection in an immunocompromised patient.
    Consigny S; Dhedin N; Datry A; Choquet S; Leblond V; Chosidow O
    Clin Infect Dis; 2003 Jul; 37(2):311-3. PubMed ID: 12856225
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.